BRIEF-Dynavax presents encouraging data from clinical trial of immuno-oncology product candidate, SD-101

* Dynavax presents encouraging data from clinical trial of

immuno-oncology product candidate, SD-101

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom; +1 646 223 8780)

Read more